{"id":25995,"date":"2020-01-14T10:16:44","date_gmt":"2020-01-14T10:16:44","guid":{"rendered":"https:\/\/www.irdd-summit.com\/?page_id=25995"},"modified":"2021-11-08T10:33:31","modified_gmt":"2021-11-08T10:33:31","slug":"mark-milton-edwards","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/","title":{"rendered":"Mark Milton-Edwards"},"content":{"rendered":"
\n\n\t

Mark Milton-Edwards<\/h2>\n

Head of Product & Health Solutions – Digital Health at Teva Pharmaceuticals<\/h4>\n\t

<\/p>\n

Mark has worked with Swellaway Ltd. for >3yrs. in a NED role with a special focus on Digital Health Regulatory, IP and commercialisation. Mark holds a full-time role for more than 13yrs with TEVA Pharmaceuticals and over 16years with AstraZeneca prior to this. Mark has held various positions including R&D Project Leader, VP Sales & Marketing, Strategic Planning & Business Development, and Global Brand Lead. Graduated in Aeronautical Sciences and completed his MBA at Durham University, UK.<\/p>\n

Mark has numerous patents granted and pending in electronic communications, sports technologies, inhaled pharmaceutical development, and respiratory physiological function & predictive AI. Mark is the inventor of Digihaler\u00ae, the first FDA approved digital inhaler with built-in sensors.<\/p>\n

<\/p>\n\t\t\t\t\t\t\t\"Mark_Milton-Edwards_Teva_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_delivery_2020_Gallery\"\t\t\t\t\t\t\t\n

\n\tDigital Pharmaceuticals: A case study\n\t<\/h3>\n\t

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

\n\t\t\t\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t

https:\/\/tevapharm.com\/<\/a><\/p>\n

\n\t\t\t\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t

Visit Profile<\/a><\/p>\n\n<\/div>","protected":false},"excerpt":{"rendered":"

Mark Milton-Edwards Head of Product & Health Solutions – Digital Health at Teva Pharmaceuticals Mark has worked with Swellaway Ltd. for >3yrs. in a NED role with a special focus on Digital Health Regulatory, IP and commercialisation. Mark holds a full-time role for more than 13yrs with TEVA Pharmaceuticals and over 16years with AstraZeneca prior…<\/p>\n","protected":false},"author":1,"featured_media":25996,"parent":15585,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-25995","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nMark Milton-Edwards • BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Mark Milton-Edwards is responsible for the Product & Health Solutions within Digital Health at TEVA Pharmaceuticals. Over ten years with TEVA and prior to that sixteen with AstraZeneca.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mark Milton-Edwards • BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Mark Milton-Edwards is responsible for the Product & Health Solutions within Digital Health at TEVA Pharmaceuticals. Over ten years with TEVA and prior to that sixteen with AstraZeneca.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-08T10:33:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/01\/Mark_Milton-Edwards_Teva_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_delivery_2020_Profile.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/\",\"name\":\"Mark Milton-Edwards • BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/01\/Mark_Milton-Edwards_Teva_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_delivery_2020_Profile.jpg\",\"datePublished\":\"2020-01-14T10:16:44+00:00\",\"dateModified\":\"2021-11-08T10:33:31+00:00\",\"description\":\"Mark Milton-Edwards is responsible for the Product & Health Solutions within Digital Health at TEVA Pharmaceuticals. Over ten years with TEVA and prior to that sixteen with AstraZeneca.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/01\/Mark_Milton-Edwards_Teva_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_delivery_2020_Profile.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/01\/Mark_Milton-Edwards_Teva_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_delivery_2020_Profile.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inhalation & Respiratory Drug Delivery 2021 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Mark Milton-Edwards\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow's healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mark Milton-Edwards • BioTech Pharma Summit","description":"Mark Milton-Edwards is responsible for the Product & Health Solutions within Digital Health at TEVA Pharmaceuticals. Over ten years with TEVA and prior to that sixteen with AstraZeneca.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/","og_locale":"en_US","og_type":"article","og_title":"Mark Milton-Edwards • BioTech Pharma Summit","og_description":"Mark Milton-Edwards is responsible for the Product & Health Solutions within Digital Health at TEVA Pharmaceuticals. Over ten years with TEVA and prior to that sixteen with AstraZeneca.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-11-08T10:33:31+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/01\/Mark_Milton-Edwards_Teva_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_delivery_2020_Profile.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/","name":"Mark Milton-Edwards • BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/01\/Mark_Milton-Edwards_Teva_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_delivery_2020_Profile.jpg","datePublished":"2020-01-14T10:16:44+00:00","dateModified":"2021-11-08T10:33:31+00:00","description":"Mark Milton-Edwards is responsible for the Product & Health Solutions within Digital Health at TEVA Pharmaceuticals. Over ten years with TEVA and prior to that sixteen with AstraZeneca.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/01\/Mark_Milton-Edwards_Teva_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_delivery_2020_Profile.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/01\/Mark_Milton-Edwards_Teva_BioTech_Pharma_Summit_IRDD_Inhalation_Respiratory_Drug_delivery_2020_Profile.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/mark-milton-edwards\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Inhalation & Respiratory Drug Delivery 2021 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/irdd-speakers\/"},{"@type":"ListItem","position":3,"name":"Mark Milton-Edwards"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow's healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/25995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=25995"}],"version-history":[{"count":8,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/25995\/revisions"}],"predecessor-version":[{"id":36887,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/25995\/revisions\/36887"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/15585"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/25996"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=25995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}